American Acquisition Opportunity Inc. (NASDAQ:AMAO) announced redemption results this afternoon as well as its new forward purchase agreement with certain accredited investors.
On Monday, March 21, AMAO held a special meeting to vote on three proposals after adjourning its meeting held on March 18. Of the 13,232,502 shares of common stock issued and outstanding and entitled to vote at Monday’s meeting, 11,206,316 shares, or 84.7%, were represented in person or by proxy.
The SPAC saw 8,943,317 shares redeemed for a pro rata portion of the funds in the trust account. As a result, 85.126%, or $90,334,512.92 at approximately $10.10 per share, of the trust will be removed to pay such holders.
As for the forward purchase agreement, AMAO also disclosed that certain Investors may each individually elect to sell and transfer to the Company via redemption on the earlier of the closing of the Company’s initial business combination and September 22, 2022 (the “Extended Date”) for an aggregate purchase price of $10.35 per share. They collectively hold 1,123,499 shares subject to the purchase agreements.


Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...